Purpose: To assess the correlation between magnetic resonance (MR) imaging findings and angiogenetic activity in hepatocellular nodules evaluated by immunohistochemical staining with antibody of vascular endothelial growth factor (VEGF).
Materials And Methods: We searched the pathologic records of our institution from December 1999 to April 2002, and included 16 patients with hepatocellular carcinoma (N = 14), large regenerative nodule (N = 1), and dysplastic nodule (N = 1) who underwent orthotopic liver transplantation (10 patients) or partial hepatectomy (six patients) and MR imaging within an interval of two weeks. The MR images were retrospectively assessed qualitatively and quantitatively. Angiogenetic activity of the hepatic nodules was evaluated by means of immunohistochemical study for VEGF. Analysis of variance and the Scheffé criterion were used for statistical evaluation.
Results: Hepatic nodules with moderate to strong immunoreactivity for VEGF showed higher signal intensity on T1-weighted images (P < 0.05) and those with intense immunoreactivity for VEGF showed higher signal intensity on T2-weighted images (P < 0.05). No correlation was found between the immunoreactivity for VEGF and tumor vascularity on postcontrast early- and late-phase images.
Conclusion: Our current results suggest that signal intensity on unenhanced T1- and T2-weighted MR images may correlate with immunoreactivity for VEGF. Correlation was not found between immunoreactivity for VEGF and signal intensity on gadolinium-enhanced MR images.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jmri.20133 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lymphovascular Tumoral Emboli in Inflammatory Breast Cancer Result from Haptotaxis-Mediated Encircling Lymphangiogenesis.
Lymphatics
December 2024
Department of Pathology, Anatomy and Cell Biology and the Clinical and Translational Research Center of Excellence, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Boulevard, Nashville, TN 37208, USA.
Inflammatory breast cancer (IBC) is characterized by numerous tumor emboli within lymphatics. In a recent study, we observed tumor embolic budding both in vitro and in vivo within lymphovascular spaces and proposed this to account for the plethora of tumor emboli seen in IBC. These observations did not address, however, how lymphovascular invasion is initiated or the mechanisms involved.
View Article and Find Full Text PDF[Evaluation of whole blood immunoreactivity].
Khirurgiia (Mosk)
December 2024
Petrovsky National Research Center of Surgery, Moscow, Russia.
To assess cellular immunoreactivity, lipopolysaccharide (LPS), Concanavalin A (Con A), or LPS together with Con A was added to the whole blood for 18 hours. LPS preferentially stimulated release of tumor necrosis factor-alfa (TNF-α), interleukin-6 (IL-6), IL-10 and vascular endothelial growth factor (VEGF) by blood cells, whereas Con A significantly enhanced secretion of interferon-gamma (IFN-gamma) and IL-2. Addition of heparin to blood slightly decreased cellular secretion of IL-2 and VEGF, but not other cytokines.
View Article and Find Full Text PDFGenetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma.
J Immunother Cancer
November 2024
Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Article Synopsis
- Ovarian clear cell carcinoma (OCCC) is a rare and resistant form of ovarian cancer, displaying varying immune responses, which complicates its treatment with immunotherapy.
- A comprehensive analysis of patient samples was conducted, utilizing single-cell sequencing and other methods, revealing that genetic mutations are linked to immune activation and poor progression-free survival, particularly with high levels of CD36 and CD47.
- Combination therapy using anti-VEGF and anti-PD-1 has shown clinical benefits, especially in cases of ongoing, recurrent, or metastatic OCCC, by enhancing immune responses within the tumor environment.
Repeated treatment with VEGF receptor inhibitors induces phenotypic changes in endothelial cells and pericytes in the rat retina.
Microvasc Res
January 2025
Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. Electronic address:
Abnormal ocular angiogenesis is a major cause of visual impairment and vision loss in neovascularization-related diseases. Currently, anti-vascular endothelial growth factor (VEGF) drugs are used to treat ocular neovascularization, but repeated injections are needed to maintain their therapeutic effects. However, repeated injection of anti-VEGF drugs may affect the retinal blood vessel phenotype and diminish therapeutic effects.
View Article and Find Full Text PDFUnveiling Lobophytum sp. the neuroprotective potential of Parkinson's disease through multifaceted mechanisms, supported by metabolomic analysis and network pharmacology.
Sci Rep
September 2024
Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, 11754, Egypt.
Article Synopsis
- - The study investigates the neuroprotective effects of Lobophytum sp. crude extract in a rat model designed to mimic Parkinson's disease, focusing on its impact on oxidative stress, inflammation, and apoptosis markers.
- - A detailed metabolomic analysis using HR-LC-ESI-MS identified 20 secondary metabolites in the extract, highlighting potential therapeutic compounds against neurodegeneration.
- - The research suggests that the extract may mitigate neurodegeneration by reducing harmful factors and enhancing neuroprotective proteins, with a prominent link established between specific compounds and Parkinson's-related genes and pathways.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!